The Law-makers

With all the recent uproar over rising health care costs, the idea of obtaining better medical care at substantially lower prices sounds like a gross improbability.

Such, however, would be the likely effect of a bill (HR-8544) promoted in the House of Representatives by Congressman Steve Symms of Idaho and co-sponsored by more than a hundred other members of that body. An identical bill (S-1683) has been offered in the upper chamber by Senators Jesse Helms of North Carolina, Barry Goldwater of Arizona, and Strom Thurmond of South Carolina. These bills would remove from the FDA the power to determine the “efficacy” of ethical drugs, limiting the agency to its more traditional role of policing safety.

MS

About the Author

M. Stanton Evans

Featured Tags

House of Representatives

With all the recent uproar over rising health care costs, the idea of obtaining better medical care at substantially lower prices sounds like a gross improbability.

Such, however, would be the likely effect of a bill (HR-8544) promoted in the House of Representatives by Congressman Steve Symms of Idaho and co-sponsored by more than a hundred other members of that body. An identical bill (S-1683) has been offered in the upper chamber by Senators Jesse Helms of North Carolina, Barry Goldwater of Arizona, and Strom Thurmond of South Carolina. These bills would remove from the FDA the power to determine the “efficacy” of ethical drugs, limiting the agency to its more traditional role of policing safety.